Reduced prevalence of allergic disease in patients with multiple sclerosis is associated with enhanced IL-12 production
Open Access
- 1 September 1998
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 102 (3) , 428-435
- https://doi.org/10.1016/s0091-6749(98)70131-9
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Asthma, nasal allergies, and multiple sclerosisJournal of Allergy and Clinical Immunology, 1997
- Differential production of IL-12 in BALB/c and DBA/2 mice controls IL-4 versus IFN-γ synthesis in primed CD4 lymphocytesInternational Immunology, 1996
- Regulation of disease susceptibility: Decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosisJournal of Allergy and Clinical Immunology, 1996
- Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.The Journal of Experimental Medicine, 1995
- Genetic Susceptibility to Asthma — Bronchial Hyperresponsiveness Coinherited with a Major Gene for AtopyNew England Journal of Medicine, 1995
- In Vitro Synthesis of IL-4 by Human CD4+ T Cells Requires Repeated Antigenic StimulationCellular Immunology, 1993
- Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.The Journal of Experimental Medicine, 1993
- Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5Genomics, 1992
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983